Live-Attenuated Measles Virus Vaccine Targets Dendritic Cells and Macrophages in Muscle of Nonhuman Primates
- 15 February 2015
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 89 (4) , 2192-2200
Abstract
Although live-attenuated measles virus (MV) vaccines have been used successfully for over 50 years, the target cells that sustain virus replication in vivo are still unknown. We generated a reverse genetics system for the live-attenuated MV vaccine strain Edmonston-Zagreb (EZ), allowing recovery of recombinant (r)MV EZ . Three recombinant viruses were generated that contained the open reading frame encoding enhanced green fluorescent protein (EGFP) within an additional transcriptional unit (ATU) at various positions within the genome. rMV EZ EGFP(1), rMV EZ EGFP(3), and rMV EZ EGFP(6) contained the ATU upstream of the N gene, following the P gene, and following the H gene, respectively. The viruses were compared in vitro by growth curves, which indicated that rMV EZ EGFP(1) was overattenuated. Intratracheal infection of cynomolgus macaques with these recombinant viruses revealed differences in immunogenicity. rMV EZ EGFP(1) and rMV EZ EGFP(6) did not induce satisfactory serum antibody responses, whereas both in vitro and in vivo rMV EZ EGFP(3) was functionally equivalent to the commercial MV EZ -containing vaccine. Intramuscular vaccination of macaques with rMV EZ EGFP(3) resulted in the identification of EGFP + cells in the muscle at days 3, 5, and 7 postvaccination. Phenotypic characterization of these cells demonstrated that muscle cells were not infected and that dendritic cells and macrophages were the predominant target cells of live-attenuated MV. IMPORTANCE Even though MV strain Edmonston-Zagreb has long been used as a live-attenuated vaccine (LAV) to protect against measles, nothing is known about the primary cells in which the virus replicates in vivo . This is vital information given the push to move toward needle-free routes of vaccination, since vaccine virus replication is essential for vaccination efficacy. We have generated a number of recombinant MV strains expressing enhanced green fluorescent protein. The virus that best mimicked the nonrecombinant vaccine virus was formulated according to protocols for production of commercial vaccine virus batches, and was subsequently used to assess viral tropism in nonhuman primates. The virus primarily replicated in professional antigen-presenting cells, which may explain why this LAV is so immunogenic and efficacious.Keywords
This publication has 42 references indexed in Scilit:
- Measles Immune Suppression: Lessons from the Macaque ModelPLOS Pathogens, 2012
- Recombinant Canine Distemper Virus Strain Snyder Hill Expressing Green or Red Fluorescent Proteins Causes Meningoencephalitis in the FerretJournal of Virology, 2012
- Wild-Type Measles Virus with the Hemagglutinin Protein of the Edmonston Vaccine Strain Retains Wild-Type Tropism in MacaquesJournal of Virology, 2012
- Early Target Cells of Measles Virus after Aerosol Infection of Non-Human PrimatesPLOS Pathogens, 2011
- In VivoTropism of Attenuated and Pathogenic Measles Virus Expressing Green Fluorescent Protein in MacaquesJournal of Virology, 2010
- Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro®) and a varicella vaccine (VARIVAX®) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trialBMC Medicine, 2009
- Predominant Infection of CD150+ Lymphocytes and Dendritic Cells during Measles Virus Infection of MacaquesPLOS Pathogens, 2007
- A Vectored Measles Virus Induces Hepatitis B Surface Antigen Antibodies While Protecting Macaques against Measles Virus ChallengeJournal of Virology, 2007
- An internal element of the measles virus antigenome promoter modulates replication efficiencyVirus Research, 2004
- Is CD46 the cellular receptor for measles virus?Virus Research, 1997